| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4004028 | American Journal of Ophthalmology | 2010 | 9 Pages |
Abstract
Combined treatment consisting of photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy seemed to be effective for improving visual acuity and reducing retreatment rates and complications. Further study is needed to determine the long-term clinical results.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Taku Sato, Shoji Kishi, Hidetaka Matsumoto, Ryo Mukai,